Adjuvant benmelstobart plus anlotinib in patients with high-risk recurrence after resection of hepatocellular carcinoma: a phase II study (ALTER-H006)
- Xiaohui Duan
- Dongde Wu
- Cuncai Zhou
- Yifeng Tian
- Wenbin Duan
- Botao Chen
- Jian Shen
- Guohui Xu
- Yannan Bai
- Xianhai Mao
2025-12-08